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Abstract: In the study, a series of twelve ring-substituted 4-hydroxy-1H-quinolin-2-one 
derivatives were prepared. The procedures for synthesis of the compounds are presented. 
The compounds were analyzed using RP-HPLC to determine lipophilicity and tested for 
their photosynthesis-inhibiting activity using spinach (Spinacia oleracea L.) chloroplasts. 
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All the synthesized compounds were also evaluated for antifungal activity using in vitro 
screening with eight fungal strains. For all the compounds, the relationships between the 
lipophilicity and the chemical structure of the studied compounds are discussed, as well as 
their structure-activity relationships (SAR). 
Keywords: Quinolinone derivatives; Lipophilicity; OER inhibition; Spinach chloroplasts; 
In vitro antifungal activity; Structure-activity relationships. 
 
1. Introduction 
The quinoline scaffold is present in many classes of biologically-active compounds [1]. A series of 
compounds derived from 8-hydroxyquinoline and styrylquinoline derivatives were recently 
synthesized as potential HIV-1 integrase inhibitors [2,3]. These compounds show a significant 
similarity to some novel antifungal agents, namely homoallylamines, and therefore possess potential 
antifungal activity [4]. Our previous study dealing with 8-hydroxyquinoline and styrylquinoline 
derivatives showed that they could also possess a strong antifungal activity [5-7]. According to the 
results reported recently, some new hydroxyquinoline derivatives also possess interesting herbicidal 
activities [6,8-13]. Some investigated compounds also showed antineoplastic activity [14]. 
Photosystem II (PS II) is a multisubunit membrane protein complex, which uses light energy to 
oxidize water and reduce plastoquinone. Binding of herbicides to photosystem II inhibits the electron 
transfer from QA to QB due to competition of herbicides with plastoquinone bound at the QB site. Thus, 
the QB quinone-binding site of photosystem II is an important target for herbicides, including 
herbicides based on phenylurea moieties. It was found that a tail can be attached to the para position of 
phenylurea-type herbicides without any loss of binding, provided that the tail is hydrophobic. This 
indicates that the herbicides must be oriented in the QB site so that these positions point toward the 
natural isoprenyl tail-binding pocket that extends out of the QB site. In turn, the requirement that the 
tail must extend out of the QB site constrains the size of the other herbicide substituents in the pocket 
[15]. In addition to phenylurea-type herbicides, various other compounds possessing an amide -
NHCO- moiety were also found to inhibit the photosynthetic electron transport [16-21]. Better 
understanding of these SAR relationships are not only important for the design of modern agricultural 
agents, but can also provide remarkable insights into the photosynthetic mechanisms of green cells. 
Over the last three decades there has been a dramatic increase in the incidence of fungal infections, 
and the discovery of new drugs for the treatment of systemic mycoses is a major challenge in 
infectious disease research. There is an intensified need for new antifungal remedies with novel modes 
of action due to the rapid growth of the immunocompromised patient population, the development of 
resistance to the present azole therapies, and high toxicity of polyenes [22-24]. 
Compounds bearing a quinoline moiety are well known due to their broad biological activity [6]. In 
particular, hydroxyquinoline and its derivatives were introduced as antifungal agents in clinical 
practice and the novel compounds of this type are still investigated [25,26]. This paper deals with 
synthesis, herbicidal and antifungal activity of ring-substituted 4-hydroxy-1H-quinolin-2-one 
derivatives. All the compounds were tested for their photosynthesis-inhibiting activity (the inhibition 
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of photosynthetic electron transport in spinach chloroplasts (Spinacia oleracea L.). Primary in vitro 
screening of all synthesized compounds was evaluated against eight fungal strains by means of the 
broth microdilution test in RPMI 1640 medium [27]. Lipophilicity (log k) of the compounds was 
determined using RP-HPLC. The procedure was performed under isocratic conditions with methanol 
as an organic modifier in the mobile phase using end-capped non-polar C18 stationary RP column. The 
structure-activity relationships of the compounds are also discussed. 
2. Results and Discussion 
2.1. Chemistry 
In most of the synthesis protocols, aniline derivatives were used as the starting materials due to 
their convenient availability from chemical providers. Microwave assisted synthesis with malonic acid 
or its esters, was used to make compounds 1-4. Further nitration and reduction according to established 
procedures were used to make compounds 5 and 6. Acylation of 6 with cinnamoyl chloride provided 
compound 7. Diazo derivative 8 was made by means of a two-step synthesis from 4-aminobenzoic acid 
and diethyl malonate and gave 4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid, which was 
coupled with the freshly prepared diazo salt derived from 4-nitro-2,5-dichloroaniline. Quinolines 
functionalized with carboxylic acid groups at C(3) 9-12 were obtained in neat microwave assisted 
synthesis in moderate or good yield. Synthesis of all the above compounds is depicted in Scheme 1. 
Scheme 1. General preparation of quinoline derivatives 1-12: (a) PPA, microwave 
irradiation; (b) HNO3; (c) Sn, HCl; (d) cinnamoyl chloride; (e) (2,5-dichloro-4-
nitrophenyl)diazonium chloride; (f) microwave irradiation; (g) hydrolysis. 
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2.2. Lipophilicity 
Hydrophobicities (log P/Clog P values) of the compounds 1-12 were calculated using two 
commercially available programs and also measured by means of the reversed phase high performance 
liquid chromatography (RP-HPLC) method for lipophilicity measurement. The procedure was 
performed under isocratic conditions with methanol as an organic modifier in the mobile phase using 
an end-capped non-polar C18 stationary RP column. The capacity factors k were determined and 
subsequent log k values were calculated.  
The results are summarized in Table 1 and illustrated in Figure 1. The results obtained with all the 
compounds show that the experimentally-determined lipophilicities (log k values) are lower than those 
indicated by the calculated log P/Clog P, as shown in Figure 1, indicating relatively poor correlation 
between the experimentally-determined log k values and the calculated values. As expected, compound 
8 showed the highest lipophilicity, while compound 3 possessed the lowest hydrophobicity, which was 
unexpected. Compound 7 showed less hydrophobicity contrary to all the results of the lipophilicity 
calculated by software. Comparing the lipophilicity data log k of both position analogues 3 and 4, it 
can be stated that the 7-hydroxy derivative 4 possessed higher hydrophobicity than 5-hydroxy 
analogue 3. The salicylic acid derivative 12 showed higher lipophilicity than benzoic derivative 11. 
These facts are caused by intramolecular interactions [28]. 
Figure 1. Comparison of the computed log P/Clog P values using the two programs with 
the calculated log k values. The discussed compounds 1-12 are ordered according to the 
log k values increase. 
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Table 1. Comparison of the calculated lipophilicities (log P/Clog P) with the determined 
log k values. 
N
H
O
OH
R2
R1
 
Comp. R1 R2 log k 
log P/Clog P 
ChemOffice 
log P 
ACD/LogP 
1 H H 0.0664 0.49 / 1.216 1.10 ± 0.75 
2 6-CH3 H 0.3307 0.97 / 1.715 1.56 ± 0.75 
3 6-COOH-5-OH H 0.0002 -0.34 / 1.261 1.47 ± 0.75 
4 6-COOH-7-OH H 0.0080 -0.34 / 1.070 2.22 ± 0.75 
5 H -NO2 0.4052 1.39 / 0.836 -0.14 ± 1.00 
6 H -NH2 0.0004 -1.06 / 0.719 -0.32 ± 1.00 
7 H 
H
N
O
0.0128 1.11 / 2.848 2.45 ± 1.00 
8 6-COOH 
N
N
NO2Cl
Cl
0.6394 5.22 / 3.840 4.41 ± 1.00 
9 H -COOC2H5 0.4595 0.51 / 1.694 1.17 ± 0.75 
10 H -COOH 0.0118 -0.09 / 1.409 1.71 ± 0.35 
11 6-COOH N
H
COOH
O
0.0081 0.27 / 2.445 1.67 ± 1.00 
12 6-COOH-5-OH N
H
COOH
O
OH 0.0093 -0.51 / 2.543 2.20 ± 1.00 
 
2.3. Oxygen evolution rate inhibition in spinach chloroplasts 
All compounds were evaluated for their in vitro herbicidal efficiency. The results are listed in Table 
2. Quinoline derivatives 1-12 showed a wide range of activity related to inhibition of oxygen evolution 
rate (OER) in spinach chloroplasts. Two compounds showed interesting IC50 (half maximal inhibitory 
concentration) values: 126 µmol/L (8) and 157 µmol/L (2); nevertheless the studied activity of all the 
other compounds was very low. 
Due to the moderate and/or low activity of compounds 1-12, it is difficult to determine simple 
structure-activity relationships. However some interesting observations can be made: in the case of 
compound 1, an unsubstituted structure did not have any effect on OER in chloroplasts. The remaining 
compounds could be divided into two groups according to their chemical structure. Group 1 includes 
compounds 2-4, 8, 11 and 12, and Group 2 compounds 5-7, 9 and 10. 
Group 1 showed higher biological activity than Group 2. The activity related to OER inhibition 
seems to be positively influenced by substitution of ring B: especially the C(6) position (see compounds 
2-4, 11, 12). Comparison of the OER-inhibiting activities of compounds 2-4, 8, 11 and 12 also 
indicated that the lipophilicity increase is connected with the quasi-parabolic increase of biological 
activity (Figure 2). 
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Table 2. IC50 values related to OER inhibition in spinach chloroplasts in comparison with 
3-(3,4-dichlorophenyl)-1,1-dimethylurea (DCMU) standard and in vitro antifungal activity 
(IC80) of compounds 1-12 compared with fluconazole (FLU) standard. 
Comp. 
OER 
inhibition 
IC50 
[μmol/L] 
MIC/IC80 [µmol/L] 
CA CT CK CG TB AF AC TM 
24h 
48h 
24h 
48h 
24h 
48h 
24h 
48h 
24h 
48h 
24h 
48h 
24h 
48h 
72h 
120h 
1 925 
500 
500 
500 
500 
500 
500
500 
500
500 
500
500 
500 
500 
500 
500 
500 
2 157 
500 
500 
500 
500 
500 
500
500 
500
500 
500
500 
500 
500 
500 
500 
500 
3 346 
125 
125 
500 
>500 
>500 
>500
250 
250 
250 
>500
500 
500 
500 
500 
500 
500 
4 538 
15.62 
62.50 
500 
>500 
>500 
>500
62.50
250 
62.50
>500
500 
>500 
>500 
>500 
>500 
>500 
5 510 
500 
500 
500 
500 
500 
500
500 
500
500 
500
500 
500 
500 
500 
500 
500 
6 775 
500 
500 
500 
500 
500 
500
500 
500
500 
500
500 
500 
500 
500 
500 
500 
7 916 
125 
125 
125 
125 
125 
125
125 
125
125 
125
125 
125 
125 
125 
125 
125 
8 126 
31.25 
125 
250 
>250 
250 
250 
250 
>250
250 
>250
125 
250 
62.50 
250 
62.50 
125 
9 494 
500 
500 
500 
500 
500 
500
500 
500
500 
500
500 
500 
500 
500 
500 
500 
10 567 
500 
500 
500 
500 
500 
500
500 
500
500 
500
500 
500 
500 
500 
500 
500 
11 380 
500 
500 
500 
500 
500 
500
500 
500
500 
500
500 
500 
500 
500 
500 
500 
12 321 
62.50 
125 
500 
>500 
>500 
>500
125 
250 
125 
>500
500 
>500 
500 
>500 
500 
>500 
DCMU 1.9 - - - - - - - - 
FLU - 
0.06 
0.12 
0.12 
125 
3.91 
15.62
0.98 
3.91 
0.24 
0.48 
125 
125 
125 
125 
1.95 
3.91 
 
It is noteworthy that there are great differences in OER inhibition levels caused by positional 
isomers 3 (6-COOH-5-OH) and 4 (6-COOH-7-OH). Introducing a further phenolic moiety in 
compound 12 (salicylic derivative) positively influenced OER inhibition. The higher inhibitory effect 
of compound 8 compared with compound 2 may have resulted from higher lipophilicity (easier 
penetration of the compound through cell walls) and/or redox properties of the nitro moiety of  
the 2,5-dichloro-4-nitrophenyldiazenyl substituent. 
Molecules 2009, 14                            
 
 
1151
Figure 2. Relationships between the OER inhibition log (1/IC50) [mmol/L] in spinach 
chloroplasts and lipophilicity (log k) of the studied compounds 1-12. 
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Generally, Group 2 compounds only caused slight inhibition of OER; nevertheless compounds 5 
and 9 were approximately twice as effective as compound 1. All these compounds possess the 
substituted position C(3) of ring A, which caused the decrease in OER inhibition compared with Group 
1 compounds. The most active compound from Group 2 was the ester 9. 
2.4. In vitro antifungal susceptibility testing 
All the compounds were tested for their in vitro antifungal activity. Compounds 1-3, 5-7, 9-11 did 
not show any activity and compounds 4, 8 and 12 showed only a moderate activity, especially against 
Candida albicans ATCC 44859. Compound 4 showed medium activity against Candida glabrata 20/I, 
and compound 8 against Trichophyton mentagrophytes 445. The activities of the compounds are 
shown in Table 2. 
Generally, it can be stated that in vitro antifungal activity depends on heteroaromatic ring A. 
Hydrogenation of ring A and introduction of keto group resulted in the loss of the antifungal effect 
compared with hydroxyquinoline derivatives [6,7]. Substitution of the C(3) position by various moieties 
did not have a significant influence on the activity. Nevertheless salicylic acid derivative 12 showed a 
higher activity compared with benzoic derivative 11, probably due to the substitution of the C(3)´ 
position by phenolic moiety. 
Unsubstituted ring B or C(6) substitution by a methyl moiety did not results in any activity. 
Substitution of phenyl ring B by 6-COOH (compounds 3, 4, 8 and 11, 12) caused the activity to 
increase. Position of the phenolic moiety seems to be a very important parameter for antifungal 
activity. While a 6-COOH-5-OH substitution pattern (compound 3) did not show any activity increase, 
introduction of 6-COOH along with a 7-OH moiety (compound 4) increased the activity significantly. 
The antifungal activity of compounds 8 and 12 was connected with 2,4-dichloro-4-nitrophenyldiazenyl 
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and 3-(4-carboxy-3-hydroxyphenylcarbamoyl) substituents, respectively. According to the results, it 
can be assumed that lipophilicity is only of secondary importance for antifungal activity. 
3. Conclusions 
A series of twelve ring-substituted 4-hydroxy-1H-quinolin-2-one derivatives were prepared and 
characterized. All the prepared quinoline derivatives were analyzed using a RP-HPLC method for the 
lipophilicity measurement and their lipophilicity was determined. The prepared compounds were 
tested for their photosynthesis-inhibiting activity (the inhibition of photosynthetic electron transport in 
spinach chloroplasts (Spinacia oleracea L.) and for their antifungal activity. (E)-3-[(2,5-Dichloro-4-
nitrophenyl)diazenyl]-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (8) showed the highest 
OER inhibition activity and 4,7-dihydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (4) and 
compound 8 possessed the highest in vitro antifungal activity within the series. 
 
4. Experimental  
 
4.1. General 
 
All reagents were purchased from Aldrich. Kieselgel 60, 0.040-0.063 mm (Merck, Darmstadt, 
Germany) was used for column chromatography. TLC experiments were performed on  
alumina-backed silica gel 40 F254 plates (Merck, Darmstadt, Germany). The plates were illuminated 
under UV (254 nm) and evaluated in iodine vapour. The melting points were determined on Boetius 
PHMK 05 (VEB Kombinat Nagema, Radebeul, Germany) and are uncorrected. Elemental analyses 
were carried out on an automatic Perkin-Elmer 240 microanalyser (Boston, USA). The purity of the 
final compounds was checked by the HPLC separation module Waters Alliance 2695 XE (Waters 
Corp., Milford, MA, U.S.A.). The detection wavelength 210 nm was chosen. The peaks in the 
chromatogram of the solvent (blank) were deducted from the peaks in the chromatogram of the sample 
solution. The purity of individual compounds was determined from the area peaks in the 
chromatogram of the sample solution. UV spectra (λ, nm) were determined on a Waters Photodiode 
Array Detector 2996 (Waters Corp., Milford, MA, U.S.A.) in ca 6×10-4 mol methanolic solution and 
log ε (the logarithm of molar absorption coefficient ε) was calculated for the absolute maximum  
λmax of individual target compounds. Infrared spectra were recorded in a Smart MIRacle™ ATR ZnSe 
for Nicolet™ 6700 FT-IR Spectrometer (Thermo Scientific, U.S.A.). Spectra are corrigated. All 1H 
NMR spectra were recorded on a Bruker AM-500 (499.95 MHz for 1H), Bruker BioSpin Corp., 
Germany. Chemicals shifts are reported in ppm () to internal Si(CH3)4, when diffused easily 
exchangeable signals are omitted. 
4-Hydroxyquinolin-2(1H)-one (1). Preparation of PPA: P2O5 (287.9 g) was added to 85% phosphoric 
acid (200 g, 118.4 mL) under stirring and microwave heating. The mixture was then heated for 15 min. 
Aniline (7 mL, 5 mmol) and malonic acid (5.2 g, 5 mmol) were thoroughly mixed with 20 g PPA and 
heated under stirring in microwave reactor at 400 W during 2×20 min with 5 min interval. The 
temperature reached 210 °C. Then the mixture was poured into crushed ice and the beige solid was 
filtered and purified by extraction with EtOH and a white crystalline compound was obtained [29]. 
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Yield 35%; Mp 340 °C; HPLC purity 97.12%; UV (nm), λmax/log ε: 231.3/3.51; IR (cm-1): 3618, 1180 
(OH), 3043 (=CH-), 1670 (lactam), 1650 (C=O), 1593 (Ph), 1522 (NH). 
4-Hydroxy-6-methylquinolin-2(1H)-one (2). The product was obtained according to the previously 
described procedure [30,31] as a light brown crystalline compound. Yield 35%; Mp 320 °C; HPLC 
purity 97.72%; UV (nm), λmax/log ε: 232.4/3.55; IR (cm-1): 3618, 1180 (OH), 3044 (=CH-), 2965, 1379 
(CH3), 1668 (lactam), 1652 (C=O), 1592 (Ph), 1522 (NH). 
4,5-Dihydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (3). Naphthalene (15.4 g, 0.12 mol) and 
malonic acid (18.7 g, 0.18 mol) were melted with stirring under temperature control (<150 °C) to 
avoid decarboxylation of the acid. POCl3 (32.9 g, 0.36 mol) was then added dropwise over 30 min and 
p-aminosalicylic acid (15.3 g, 0.1 mol) was then added. The resulting mixture was heated for 30 min 
and allowed to cool. Water (100 mL) was added to the warm mixture and the solution was made 
alkaline to pH 9 with 20% NaOH. After cooling on ice precipitated naphthalene, it was filtered and the 
filtrate was acidified to pH 2. The product was filtered again and crystallized from acetic acid as a 
bright yellow crystalline compound. Yield 36%; Mp 250 °C; Anal. calc. for C10H7NO5 (221.16): C 
54.31%, H 3.19%; found: C 54.51%, H 4.11%; HPLC purity 98.74%; UV (nm), λmax/log ε: 244.2/3.54; 
IR (cm-1): 3620, 1180 (OH), 3045 (=CH-), 2950, 1690 (acid), 1672 (lactam), 1650 (C=O), 1598 (Ph), 
1523 (NH), 1329, 1198 (OHphenol); 1H-NMR (DMSO-d6) : 5.65 (s, 1H), 6.60 (d, J=8.3 Hz, 1H), 7.80 
(d, J=8.3 Hz, 1H), 11.3 (bs, 1H), 12.20 (bs, 1H). 
4,7-Dihydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (4). The product was obtained as an 
isomer of 3 during its synthesis. Isolated by fractional crystalization as a white crystalline compound. 
Yield 36%; Mp 250 °C; Anal. calc. for C10H7NO5 (221.16): C 54.31%, H 3.19%; found: C 54.09%, H 
3.52%; HPLC purity 98.51%; UV (nm), λmax/log ε: 243.0/3.54; IR (cm-1): 3618, 1181 (OH), 3043 
(=CH-), 2948, 1693 (acid), 1670 (lactam), 1651 (C=O), 1599 (Ph), 1521 (NH), 1328, 1200 (OHphenol); 
1H-NMR (DMSO-d6) δ: 5.60 (s, 1H), 6.67 (s, 1H), 8.25 (s, 1H). 
4-Hydroxy-3-nitroquinolin-2(1H)-one (5). The product was obtained according to the described 
nitration procedure [32] as a yellow crystalline compound. Yield 71%; Mp 252-255 °C; HPLC purity 
99.72%; UV (nm), λmax/log ε: 336.8/3.57; IR (cm-1): 3620, 1181 (OH), 1712 (C=O), 1682 (lactam), 
1622 (C=Ccycle), 1595 (Ph), 1547 (NO2), 1525 (NH). 
3-Amino-4-hydroxyquinolin-2(1H)-one (6). Compound 6 (2.0 g, 0.0097 mol) and tin powder  
(3.8 g, 0.032 mol) were stirred with 36% HCl (8.1 mL). The mixture was warmed at 80-90 °C for  
30 min. The brown solution was cooled to room temperature and filtered. The filtrate was alkalized 
with NH3(aq) and warmed for 20 min. Then Celite (1.3 g) was added and filtered. The solid was washed 
thoroughly with hot water (80 °C). The combined filtrates were concentrated and acidified. After 
cooling a white crystalline compound was obtained. Yield 85%; Mp 300 °C [33]; HPLC purity 
91.99%; UV (nm), λmax/log ε: 232.8/3.53; IR (cm-1): 3620, 1181 (OH), 3312, 1618 (NH2), 1670 
(lactam), 1650 (C=O), 1625 (C=Ccycle), 1598 (Ph), 1523 (NH). 
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(2E)-N-(4-Hydroxy-2-oxo-1,2-dihydroquinolin-3-yl)-3-phenylprop-2-enamide (7). Compound 7 (0.018 
g, 0.001 mol) was mixed with water (5 mL), Et2O (5 mL) and sodium bicarbonate (0.3 g). The resulted 
mixture was stirred in an ice bath (-3 °C) and 10 mL of Et2O solution of cinamoyl chloride (0.017 g, 
0.001 mol) was added slowly. The resulting mixture was stirred at room temperature for  
2 days, cooled in fridge and filtered. Et2O was added to the solid and dried. A white crystalline 
compound was obtained. Yield 50%; Mp 145 °C; Anal. calc. for C18H14N2O3+H2O (324.33): C 
66.66%, H 4.97%; found: C 66.54%, H 5.27%; HPLC purity 99.79%; UV (nm), λmax/log ε: 263.1/3.51; 
IR (cm-1): 3620, 1180 (OH), 3035 (CHarom), 1670 (lactam), 1650 (C=O), 1648 (amide), 1628 
(C=Ccycle), 1618, 974 (C=C), 1599 (Ph), 1525 (NH); 1H-NMR (DMSO-d6) : 3.30 (s, 1H), 6.50 (d, 
J=16.2 Hz, 2H), 7.10 (s, 1H), 7.38 (m, 9H), 7.5 (s, 1H). 
(E)-3-[(2,5-Dichloro-4-nitrophenyl)diazenyl]-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic 
acid (8). 4-Hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid was obtained as compound 3 from 
4-aminobenzoic acid and used without thorough purification in further synthesis as follows. IR (cm-1): 
3618, 1179 (OH), 3043 (=CH-), 2948, 1686 (acid), 1677 (lactam), 1650 (C=O), 1599 (Ph), 1523 (NH); 
1H-NMR (DMSO-d6) δ: 7.7 (s, 1H), 7.9 (m, 3H), 10.43 (s, 1H), 10.47 (s, 1H), 12.7 (s, 1H). 2,5-
Dichloro-4-nitroaniline (0.92 g) was dissolved in 2:1 Et2O/EtOH , then 15% HCl (0.91 mL) was added 
to this solution and the mixture was cooled to 5 °C. NaNO2 (0.4 g, 5.7 mmol) and  
4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (1.0 g, 5.7 mmol) was added slowly under 
the temperature of 5 °C and pH<7 (15% HCl). The resulting mixture was left in ice overnight. The 
precipitated solid was then filtered and crystallized from Et2O/EtOH. A reddish crystalline compound 
was obtained. Yield 64%; Mp 340 °C; Anal. calc. for C16H8Cl2N4O6 (423.16): C 45.41%, H 1.91%; 
found: C 45.26%, H 2.24%; HPLC purity 96.39%; UV (nm), λmax/log ε: 271.4/3.61; IR (cm-1): 3616, 
1180 (OH), 3030 (CHarom), 2950, 1680 (acid), 1670 (lactam), 1655 (C=O), 1630 (C=Ccycle), 1614 
(N=N), 1598 (Ph), 1543 (NO2), 1520 (NH); 1H-NMR (DMSO-d6) δ: 5.70 (s, 1H), 7.10-7.60 (m, 3H), 
11.10 (s, 1H), 11.30 (s, 1H). 
Ethyl 4-hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylate (9). Aniline (0.46 mL, 0.005 mol) and 
triethyl methanetricarboxylate (2.12 mL, 0.01 mol) were heated in microwave reactor for 8 min at 60% 
power level. The mixture was then cooled to room temperature and 7 mL of Et2O was added. The 
crude product was crystallized from MeOH. A white crystalline compound was obtained. Yield 50%; 
Mp 116-120 °C; Anal. calc. for C12H11NO4 (233.22): C 61.80%, H 4.75%; found: C 61.65%, H 4.39%; 
HPLC purity 95.01%; UV (nm), λmax/log ε: 244.2/3.59; IR (cm-1): 3620, 1180 (OH), 2958 (CH3), 2925 
(CH2), 1680 (lactam), 1638 (C=O), 1630 (C=Ccycle), 1598 (Ph), 1520 (NH), 1191 (C=Oester); 1H-NMR 
(DMSO-d6) : 1.19 (t, 3H), 4.17 (q, 2H), 4.70 (s, 1H), 7.09 (t, 2H), 7.32 (t, 1H), 7.52 (d, J=8.5 Hz, 
1H), 10.30 (t, 1H). 
4-Hydroxy-2-oxo-1,2-dihydroquinoline-3-carboxylic acid (10). The product was obtained according to 
the described procedure [34,35] as a white crystalline compound. Yield 99%; Mp 225 °C; HPLC 
purity 99.51%; UV (nm), λmax/log ε: 250.1/3.52; IR (cm-1): 3621, 1182 (OH), 2965, 1670 (acid), 1679 
(lactam), 1646 (C=O), 1629 (C=Ccycle), 1599 (Ph), 1525 (NH). 
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3-(4-Carboxyphenylcarbamoyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid (11). 
4-Aminobenzoic acid (0.7 g, 0.005 mol) was mixed with triethyl methanetricarboxylate (2.12 mL,  
0.01 mol) and heated in microwave reactor at 50% of power during 15 min and 3 min at 90%. The 
temperature reached 231 °C during heating. Et2O was added to the cooled mixture and the precipitate 
was washed with hot (55 °C) MeOH to obtain the pure product as a yellow crystalline compound. 
Yield 62%; Mp 340-350 °C; Anal. calc. for C18H12N2O7 (368.29): C 58.70%, H 3.28%; found: C 
58.09%, H 3.54%; HPLC purity 97.52%; UV (nm), λmax/log ε: 251.3/3.53; IR (cm-1): 3621, 1180 
(OH), 3034 (CHarom), 2970, 1689 (acid), 1680 (lactam), 1642 (C=O), 1635 (C=Ccycle), 1630 (amide), 
1599 (Ph), 1520 (NH); 1H-NMR (DMSO-d6) : 7.41 (d, J=8.5 Hz, 1H), 7.70 (d, J=9.1 Hz, 2H), 7.90 
(d, J=9.1 Hz, 2H), 8.15 (d, J=8.5 Hz, 1H), 8.50 (s, 1H), 12.40 (s, 1H), 12.95 (s, 1H), 16 (s, 1H). 
3-(4-Carboxy-3-hydroxyphenylcarbamoyl)-4-hydroxy-2-oxo-1,2-dihydroquinoline-6-carboxylic acid 
(12). 4-Aminosalicylic acid (0.7 g, 0.005 mol) was mixed with triethyl methanetricarboxylate (2.12 
mL, 0.01 mol) and heated in microwave reactor at 50% of power for  
15 min and 3 min at 90%. The temperature reached 230 °C during heating. Et2O was added to the 
cooled mixture and the precipitate was washed with hot (55 °C) MeOH to obtain the pure product as a 
yellow crystalline compound. Yield 20%; Mp 350 °C; Anal. calc. for C18H12N2O9 (400.29): C 54.01%, 
H 3.02%; found: C 54.05%, H 9.94%; HPLC purity 96.42%; UV (nm), λmax/log ε: 256.0/3.53; IR  
(cm-1): 3620, 1179 (OH), 3035 (CHarom), 2972, 1688 (acid), 1680 (lactam), 1640 (C=O), 1633 
(C=Ccycle), 1632 (amide), 1600 (Ph), 1521 (NH), 1329, 1199 (OHphenol); 1H-NMR (DMSO-d6) : 7.43 
(d, J=8.5 Hz, 2H), 7.7 (s, 1H), 7.9 (m, 3H), 10.43 (s, 1H), 10.47 (s, 1H), 12.7 (s, 1H) 16.0 (s, 1H). 
4.2. Lipophilicity HPLC determination (capacity factor k / calculated log k) 
The HPLC separation module Waters Alliance 2695 XE and Waters Photodiode Array Detector 
2996 (Waters Corp., Milford, MA, U.S.A.) were used. A Symmetry® C18 5 μm, 4.6  250 mm, Part 
No. WAT054275, (Waters Corp., Milford, MA, U.S.A.) chromatographic column was used. The 
HPLC separation process was monitored by Millennium32® Chromatography Manager Software, 
Waters 2004 (Waters Corp., Milford, MA, U.S.A.). The mixture of MeOH p.a. (55.0%) and H2O-
HPLC – Mili-Q Grade (45.0%) was used as a mobile phase. The total flow of the column was 0.9 
mL/min, injection 30 μL, column temperature 30 °C and sample temperature 10 °C. The detection 
wavelength 210 nm was chosen. The KI methanolic solution was used for the dead time (TD) 
determination. Retention times (tR) were measured in minutes. The capacity factors k were calculated 
using the Millennium32® Chromatography Manager Software according to formula k = (tR - tD) / tD, 
where tR is the retention time of the solute, whereas tD denotes the dead time obtained via an 
unretained analyte. Log k, calculated from the capacity factor k, is used as the lipophilicity index 
converted to log P scale. The log k values of the individual compounds are shown in Table 1. 
4.3. Lipophilicity calculations 
Log P, i.e. the logarithm of the partition coefficient for n-octanol/water, was calculated using the 
programs CS ChemOffice Ultra ver. 9.0 (CambridgeSoft, Cambridge, MA, U.S.A.) and ACD/LogP 
ver. 1.0 (Advanced Chemistry Development Inc., Toronto, Canada). Clog P values (the logarithm of  
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n-octanol/water partition coefficient based on established chemical interactions) were generated by 
means of CS ChemOffice Ultra ver. 9.0 (CambridgeSoft, Cambridge, MA, U.S.A.) software. The 
results are shown in Table 1. 
4.4. Study of inhibition of oxygen evolution rate (OER) in spinach chloroplasts 
Chloroplasts were prepared from spinach (Spinacia oleracea L.) according to Masarovicova and 
Kralova [36]. The inhibition of photosynthetic electron transport (PET) in spinach chloroplasts was 
determined spectrophotometrically (Genesys 6, Thermo Scientific, U.S.A.) using an artificial electron 
acceptor 2,6-dichlorophenol-indophenol (DCPIP) according to Kralova et al. [37] and the rate of 
photosynthetic electron transport was monitored as a photoreduction of DCPIP. The measurements 
were carried out in phosphate buffer (0.02 mol/L, pH 7.2) containing sucrose (0.4 mol/L), MgCl2 
(0.005 mol/L) and NaCl (0.015 mol/L). The chlorophyll content was 30 mg/L in these experiments and 
the samples were irradiated (~100 W/m2) from 10 cm distance with a halogen lamp (250 W) using a  
4 cm water filter to prevent warming of the samples (suspension temperature 22 °C). The studied 
compounds were dissolved in DMSO due to their limited water solubility. The applied DMSO 
concentration (up to 4%) did not affect the photochemical activity in spinach chloroplasts. The 
inhibitory efficiency of the studied compounds was expressed by IC50 values, i.e. by molar 
concentration of the compounds causing 50% decrease in the oxygen evolution rate relative to the 
untreated control. The comparable IC50 value for a selective herbicide 3-(3,4-dichlorophenyl)-1,1-
dimethylurea, DCMU (Diurone®) was about 1.9 μmol/L [38]. The results are summarized in Table 2. 
4.4. In vitro antifungal susceptibility testing 
The broth microdilution test [27,39] was used for the assessment of in vitro antifungal activity of 
the synthesized compounds against Candida albicans ATCC 44859 (CA), Candida tropicalis 156 
(CT), Candida krusei ATCC 6258 (CK), Candida glabrata 20/I (CG), Trichosporon beigelii 1188 
(TB), Aspergillus fumigatus 231 (AF), Absidia corymbifera 272 (AC), and Trichophyton 
mentagrophytes 445 (TM). Fluconazole (FLU) was used as the standard of a clinically used 
antimycotic drug. The procedure was performed with twofold dilution of the compounds in RPMI 
1640 (Sevapharma a.s., Prague, Czech Republic) buffered to pH 7.0 with 0.165 mol of 3-morpholino-
propane-1-sulfonic acid (MOPS, Sigma, Germany). The final concentrations of the compounds ranged 
from 500 to 0.975 μmol/l. Drug–free controls were included. The MIC was defined as an 80% or 
greater (IC80) reduction of growth in comparison with the control. The values of MICs were 
determined after 24 and 48 h of static incubation at 35 °C. For T. mentagrophytes, the final MICs were 
determined after 72 and 120 h of incubation. The results are summarized in Table 2. 
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